The US Food and Drug Administration (FDA) has said that it remains concerned about the risk of blood clots with the use of drospirenone-containing birth control pills, including those made by German drug company Bayer.
In a safety announcement on Monday, the agency said that preliminary results of a study that it funded, involving 800,000 women, suggested an approximately 1.5-fold increase in the risk of blood clots for women who use the drospirenone-containing pills compared with users of other hormonal contraceptives.
Go deeper with GlobalData
Bayer’s best selling birth control drugs, including Yaz and Yasmin, contain the compound.
The FDA has scheduled a joint meeting with the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on 8 December to discuss the risks and benefits of the pills.
The agency has completed its review of two studies evaluating the risk of blood clots in women, but has not reached a conclusion yet.
See Also:
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
